Valsartan and Zantac Cancer Lawsuits │You Could Be Owed Compensation

NDMA (N-nitrosodimethylamine) is an extremely toxic substance, widely considered carcinogenic in humans and was once used as an ingredient in rocket fuel but it’s use was discontinued when it was found in the air, water and soil near a rocket manufacturing plant.  NDMA is only produced in the United States for use as a research chemical – it is so toxic that it is used by scientists to induce cancer in lab rats.  NDMA is also a chemical byproduct in varying industrial manufacturing and refining processes.

On July 13, 2018 the FDA began recalling Valsartan manufactured by Chinese manufacturer Zhejang Huahai Pharmaceuticals and distributed by pharmaceutical giants Teva Pharmaceuticals, Major® Pharmaceuticals and Solco Healthcare.  The Valsartan recall has become one of the largest pharmaceutical recalls ever, expanding several times since the initial recall: on August 10, 2018, on August 22, 2018, on September 28, 2018, on October 24, 2018, on November 21, 2018, on November 27, 2018, on December 6, 2018, on December 11, 2018, January 2, 2019 and, finally, on March 1, 2019.  Learn more about the FDA recalls here.

Not all Valsartan has been recalled so it is important that you DO NOT DISCONTINUE VALSARTAN USE WITHOUT SPEAKING TO YOUR PRESCRIBER FIRST. Any Valsartan prescription filled after March 1, 2019 should not be subject to the any FDA recalls.

On September 13, 2019 the FDA began recalling the popular heartburn medication, Zantac, due to the presence of NDMA.  The recall includes both prescription and over-the-counter Zantac.  The exact nature of NDMA problems with Zantac is unknown.  Regulators are unsure if the medication was contaminated during the manufacture and distribution process or if the NDMA contamination is the result of a chemical reaction among the ingredients of Zantac itself.  In either event, consumers should have never been exposed to this dangerous chemical.

Loncar Associates is evaluating cases for individual products liability litigation for anyone who used Valsartan or Zantac since January 1, 2012 and were diagnosed with any of the following cancers after using the contaminated medications:

  1. Colon/colorectal cancer
  2. Small intestine cancer
  3. Kidney cancer
  4. Stomach cancer
  5. Liver cancer
  6. Bladder cancer
  7. Esophageal cancer
  8. Pancreatic cancer
  9. non-Hodgkin’s lymphoma
  10. leukemia
  11. multiple myeloma
  12. Prostate cancer in men under 65 years of age only

The law places time limits in which litigation must be initiated, called statutes of limitations and repose. Failure to timely file your lawsuit can and likely will result in your justice being denied. These time limits can deny you compensation even if you are not aware that you have a case.

Since 1999, Loncar Associates has been at the forefront of pharmaceutical and medical device litigation nationwide. Our clients have obtained successful verdicts for their injuries. Don’t wait until it is too late. Contact the law offices of Loncar Associates immediately for a free, no-obligation evaluation of your potential case.  Don’t be a victim twice. The justice-makers at Loncar Associates are standing by to discuss your case and your legal options. Call 800-285-HURT (4878) or complete the contact form immediately to discuss your case with an experienced member of our legal team.

Related Posts